Combining chemotherapy and autologous peptide‐pulsed dendritic cells provides survival benefit in stage IV melanoma patients

BACKGROUND AND OBJECTIVES: We examined retrospectively whether the combination of standard dacarbazine (DTIC) and/or fotemustine chemotherapy and autologous peptide‐loaded dendritic cell (DC) vaccination may improve survival of stage IV melanoma patients. Furthermore, a small cohort of long‐term sur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Dtsch Dermatol Ges
Main Authors: Eisendle, Klaus, Weinlich, Georg, Ebner, Susanne, Forstner, Markus, Reider, Daniela, Zelle‐Rieser, Claudia, Tripp, Christoph H., Fritsch, Peter, Stoitzner, Patrizia, Romani, Nikolaus, Nguyen, Van Anh
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Originalarbeiten
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7756560/
https://ncbi.nlm.nih.gov/pubmed/33197129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ddg.14334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados